Ms Sasha Parikh Staff Accountant Division of Corporation Finance Securities and Exchange Commission 100 F Street, NE Washington, D.C. 20549 |
VIA EDGAR AND FEDERAL EXPRESS
October 4, 2012 |
Re: Sanofi
Form 20-F for Fiscal Year Ended December 31, 2011
Filed March 6, 2012
File No. 001-31368
Dear Ms Parikh,
This is a follow up to your letter dated September 21, 2012 addressed to Mr. Christopher Viehbacher, Chief Executive Officer of Sanofi.
This letter is to confirm that Sanofi is in the process of gathering information responsive to the Staff’s aforementioned comment letter and intends to respond to the comment letter no later than October 19, 2012.
Please do not hesitate to contact John Felitti at 011 + 33 1 53 77 48 96 if you have any questions.
Very truly yours,
Laurent Gilhodes |
Vice President, Group Accounting & Asset Valuation |
cc: | Jérôme Contamine, Executive Vice President, Chief Financial Officer |
John Felitti, Associate Vice-President, Corporate Law, Finance & Securities Law
54, rue La Boétie, 75414 Paris Cedex 8, France - Tél. : +33 (0)1.53.77.40.00 - Fax : +33 (0)1.53.77.41.33 - www.sanofi.com
SANOFI - Siège social : 54, rue La Boétie, 75008 Paris, France - S.A. au capital de 2 681 837 622 € - 395 030 844 R.C.S. Paris - Code APE 7010 Z - N° intracommunautaire : FR 88395030844